Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.

DeCuir J, Surie D, Zhu Y, Lauring AS, Gaglani M, McNeal T, Ghamande S, Peltan ID, Brown SM, Ginde AA, Steinwand A, Mohr NM, Gibbs KW, Hager DN, Ali H, Frosch A, Gong MN, Mohamed A, Johnson NJ, Srinivasan V, Steingrub JS, Khan A, Busse LW, Duggal A, Wilson JG, Qadir N, Chang SY, Mallow C, Kwon JH, Exline MC, Shapiro NI, Columbus C, Vaughn IA, Ramesh M, Safdar B, Mosier JM, Casey JD, Talbot HK, Rice TW, Halasa N, Chappell JD, Grijalva CG, Baughman A, Womack KN, Rhoads JP, Swan SA, Johnson C, Lewis N, Ellington S, Dawood FS, McMorrow M, Self WH, Investigating Respiratory Viruses in the Acutely Ill (IVY) Network

Open source

DOI
10.1111/irv.70027
Published
2024 Nov
Container
Influenza and other respiratory viruses
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/irv.70027,
  title = {Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.},
  author = {DeCuir J and Surie D and Zhu Y and Lauring AS and Gaglani M and McNeal T and Ghamande S and Peltan ID and Brown SM and Ginde AA and Steinwand A and Mohr NM and Gibbs KW and Hager DN and Ali H and Frosch A and Gong MN and Mohamed A and Johnson NJ and Srinivasan V and Steingrub JS and Khan A and Busse LW and Duggal A and Wilson JG and Qadir N and Chang SY and Mallow C and Kwon JH and Exline MC and Shapiro NI and Columbus C and Vaughn IA and Ramesh M and Safdar B and Mosier JM and Casey JD and Talbot HK and Rice TW and Halasa N and Chappell JD and Grijalva CG and Baughman A and Womack KN and Rhoads JP and Swan SA and Johnson C and Lewis N and Ellington S and Dawood FS and McMorrow M and Self WH and Investigating Respiratory Viruses in the Acutely Ill (IVY) Network},
  year = {2024},
  journal = {Influenza and other respiratory viruses},
  doi = {10.1111/irv.70027},
  url = {https://doi.org/10.1111/irv.70027}
}

RIS

TY  - JOUR
TI  - Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.
AU  - DeCuir J
AU  - Surie D
AU  - Zhu Y
AU  - Lauring AS
AU  - Gaglani M
AU  - McNeal T
AU  - Ghamande S
AU  - Peltan ID
AU  - Brown SM
AU  - Ginde AA
AU  - Steinwand A
AU  - Mohr NM
AU  - Gibbs KW
AU  - Hager DN
AU  - Ali H
AU  - Frosch A
AU  - Gong MN
AU  - Mohamed A
AU  - Johnson NJ
AU  - Srinivasan V
AU  - Steingrub JS
AU  - Khan A
AU  - Busse LW
AU  - Duggal A
AU  - Wilson JG
AU  - Qadir N
AU  - Chang SY
AU  - Mallow C
AU  - Kwon JH
AU  - Exline MC
AU  - Shapiro NI
AU  - Columbus C
AU  - Vaughn IA
AU  - Ramesh M
AU  - Safdar B
AU  - Mosier JM
AU  - Casey JD
AU  - Talbot HK
AU  - Rice TW
AU  - Halasa N
AU  - Chappell JD
AU  - Grijalva CG
AU  - Baughman A
AU  - Womack KN
AU  - Rhoads JP
AU  - Swan SA
AU  - Johnson C
AU  - Lewis N
AU  - Ellington S
AU  - Dawood FS
AU  - McMorrow M
AU  - Self WH
AU  - Investigating Respiratory Viruses in the Acutely Ill (IVY) Network
PY  - 2024
JO  - Influenza and other respiratory viruses
DO  - 10.1111/irv.70027
UR  - https://doi.org/10.1111/irv.70027
ER  - 

APA

J, D., D, S., Y, Z., AS, L., M, G., T, M., S, G., ID, P., SM, B., AA, G., A, S., NM, M., KW, G., DN, H., H, A., A, F., MN, G., A, M., NJ, J., V, S., JS, S., A, K., LW, B., A, D., JG, W., N, Q., SY, C., C, M., JH, K., MC, E., NI, S., C, C., IA, V., M, R., B, S., JM, M., JD, C., HK, T., TW, R., N, H., JD, C., CG, G., A, B., KN, W., JP, R., SA, S., C, J., N, L., S, E., FS, D., M, M., WH, S., & Network, I. R. V. I. T. A. I. (. (2024). Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.. Influenza and other respiratory viruses. https://doi.org/10.1111/irv.70027

Source records